Anebulo Pharmaceuticals Q1 EPS $(0.10) Beats $(0.12) Estimate
Anebulo Pharmaceuticals Q1 EPS $(0.10) Beats $(0.12) Estimate
Anebulo Pharmicals 第一季度每股收益（0.10 美元）高於美元（0.12）的預期
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year.
Anebulo Pharmicals（納斯達克股票代碼：ANEB）公佈季度每股虧損0.10美元，比分析師普遍估計的0.12美元（0.12美元）高出16.67％。這比去年同期每股虧損0.11美元（0.11美元）增加了9.09％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。